LoPriore Vincent S
Transaction: 08/03/2026
BUY
Change
+8,000,000
Price
$0.06
Filing
08/12/2026
Type
BUY
Hepion Pharmaceuticals, Inc.
HEPA • Biotechnology
Extraordinary move
HEPA+33.33%
vs. previous close $0.07
$0.09
▲ +0.02 (+33.33%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$1.43M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.02Healthy liquidity · 10.25Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:42 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.09
Change33.33%
Shares Out16.19M
Market Cap$1.43M
Enterprise Value$-203.61K
52W Range0.03 - 0.11
Beta1.65
P/E-0.45
P/B1.11
P/FCF-0.89
EV/EBITDA0.07
EV/FCF0.13
Price$0.09
Change33.33%
Shares Out16.19M
Market Cap$1.43M
Enterprise Value$-203.61K
52W Range0.03 - 0.11
Beta1.65
P/E-0.45
P/B1.11
P/FCF-0.89
EV/EBITDA0.07
EV/FCF0.13
Earnings Yield-223.75%
FCF Yield-111.87%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.02
Current Ratio10.25
Quick Ratio10.25
Target$70.00
Target Upside79445.45%
Target Median$70.00
Target Range70.00 - 70.00
Volume66.38K
Avg Volume25.88K
EPS Surprise87.38
Investment DNA
How strong this company looks for long-term investors
48
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Manageable debt level · 0.02Healthy liquidity · 10.25Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 3 analyst votes · 2026-09-05
67/100
Neutral
Bullish
1
Hold
2
Bearish
0
Price Target
2026-08-14
Low
$70.00
Mean
$70.00
Median
$70.00
High
$70.00
Insider Transactions
Recent executive and insider activity
LoPriore Vincent S
Transaction: 08/03/2026
BUY
Change
+8,000,000
Price
$0.05
Filing
08/12/2026
Type
BUY
Appajosyula Sireesh
Transaction: 08/03/2026
BUY
Change
+2,000,000
Price
$0.06
Filing
08/12/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| LoPriore Vincent S | BUY | +8,000,000 | $0.06 | 08/03/2026 | 08/12/2026 |
| LoPriore Vincent S | BUY | +8,000,000 | $0.05 | 08/03/2026 | 08/12/2026 |
| Appajosyula Sireesh | BUY | +2,000,000 | $0.06 | 08/03/2026 | 08/12/2026 |
| Appajosyula Sireesh | BUY | +2,000,000 | $0.05 | 08/03/2026 | 08/12/2026 |
| Purcell Michael J. | BUY | +2,000,000 | $0.06 | 08/03/2026 | 08/12/2026 |
| Purcell Michael J. | BUY | +2,000,000 | $0.05 | 08/03/2026 | 08/12/2026 |
| Stetz Gary S. | BUY | +2,000,000 | $0.06 | 08/03/2026 | 08/12/2026 |
| Stetz Gary S. | BUY | +2,000,000 | $0.05 | 08/03/2026 | 08/12/2026 |
| Stetz Gary S. II | BUY | +500,000 | $0.06 | 08/03/2026 | 08/12/2026 |
| Stetz Gary S. II | BUY | +500,000 | $0.05 | 08/03/2026 | 08/12/2026 |
| Black Global 5 LLC | OTHER | +10,000,000 | $0.06 | 08/03/2026 | 08/07/2026 |
| Black Global 5 LLC | OTHER | 0 | Not reported | 08/03/2026 | 08/07/2026 |
| Stetz Gary S. II | OTHER | 0 | Not reported | 07/01/2026 | 07/10/2026 |
| Fisher Danina | OTHER | 0 | Not reported | 07/01/2026 | 07/08/2026 |
| LoPriore Chase | OTHER | 0 | Not reported | 03/16/2026 | 05/26/2026 |
| Stetz Gary S. | BUY | +1,250,000 | $0.04 | 04/21/2026 | 04/27/2026 |
| Appajosyula Sireesh | BUY | +1,250,000 | $0.04 | 04/21/2026 | 04/27/2026 |
| LoPriore Vincent S | BUY | +5,000,000 | $0.04 | 04/21/2026 | 04/27/2026 |
| Purcell Michael J. | BUY | +1,250,000 | $0.04 | 04/21/2026 | 04/27/2026 |
| Appajosyula Sireesh | OTHER | 0 | Not reported | 03/16/2026 | 03/18/2026 |